{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:11:15Z","timestamp":1785305475633,"version":"3.55.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1097\/dss.0000000000000065","type":"journal-article","created":{"date-parts":[[2014,7,29]],"date-time":"2014-07-29T14:29:09Z","timestamp":1406644149000},"page":"874-882","source":"Crossref","is-referenced-by-count":29,"title":["Q-Switched Nd"],"prefix":"10.1097","volume":"40","author":[{"given":"Alaa E. A.","family":"Moubasher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman M. K.","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa A. E.","family":"Abou-Taleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210206","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/archderm.1995.01690240119022","article-title":"Melasma. Etiologic and therapeutic considerations.","volume":"131","author":"Grimes","year":"1995","journal-title":"Arch Dermatol"},{"key":"R2-8-20210206","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.det.2007.04.006","article-title":"Therapeutic approaches in melasma.","volume":"25","author":"Prignano","year":"2007","journal-title":"Dermatol Clin"},{"key":"R3-8-20210206","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaad.2010.12.046","article-title":"Melasma: a comprehensive update, part I.","volume":"65","author":"Sheth","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R4-8-20210206","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaad.2009.10.051","article-title":". Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method.","volume":"64","author":"Pandya","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R5-8-20210206","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1524-4725.2009.01383.x","article-title":"Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians.","volume":"36","author":"Wattanakrai","year":"2010","journal-title":"Dermatol Surg"},{"key":"R6-8-20210206","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-4362.2003.01621.x","article-title":". A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in treatment of melasma.","volume":"42","author":"Haddad","year":"2003","journal-title":"Int J Dermatol"},{"key":"R7-8-20210206","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jaad.2006.02.009","article-title":"The treatment of melasma: a review of clinical trials.","volume":"55","author":"Gupta","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R8-8-20210206","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/j.jaad.2005.12.039","article-title":"Treatment of melasma.","volume":"54","author":"Rendon","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R9-8-20210206","first-page":"CD003583","article-title":"Interventions for melasma (review).","volume":"7","author":"Rajaratnam","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"R10-8-20210206","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2133.2006.07590.x","article-title":"Guidelines for clinical trials in melasma.","volume":"156","author":"Pandya","year":"2006","journal-title":"Br J Dermatol"},{"key":"R12-8-20210206","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1067\/mjd.2000.104894","article-title":"Effects of glycolic acid on light-induced skin pigmentation in Asian and Caucasian subjects.","volume":"43","author":"Tsai","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"R13-8-20210206","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/14764170902842549","article-title":". Melasma: Treatment evaluation.","volume":"11","author":"Salem","year":"2009","journal-title":"J Cosmet Laser Ther"},{"key":"R14-8-20210206","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1473-2165.2009.00471.x","article-title":". Different therapeutic modalities for treatment of melasma.","volume":"8","author":"Azzam","year":"2009","journal-title":"J Cosmet Dermatol"},{"key":"R15-8-20210206","first-page":"79","article-title":"Comparative efficacy of 20 trichloroacetic acid and 50 glycolic acid peels in treatment of recalcitrant melasma.","volume":"16","author":"Dogra","year":"2006","journal-title":"J Pak Assoc Derma"},{"key":"R16-8-20210206","first-page":"962","article-title":"Efficacy and safety of Q-switched 1064 neodymium-doped yttrium aluminium laser treatment of melasma.","volume":"37","author":"Zhou","year":"2011","journal-title":"Dermatol Surg"},{"key":"R17-8-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1524-4725.2010.01523.x","article-title":". Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.","volume":"36","author":"Jeong","year":"2010","journal-title":"Dermatol Surg"},{"key":"R18-8-20210206","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1473-2165.2007.00302.x","article-title":"Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study.","volume":"6","author":"Soliman","year":"2007","journal-title":"J Cosmet Dermatol"},{"key":"R19-8-20210206","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0019-5154.48985","article-title":"A study comparing chemical peeling using modified jessners solution and 15 trichloroacetic acid versus 15 trichloroacetic acid in the treatment of melasma.","volume":"54","author":"Safoury","year":"2009","journal-title":"Indian J Dermatol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000000065","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:21:37Z","timestamp":1620951697000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042728-201408000-00008"}},"subtitle":["YAG Laser Versus Trichloroacetic Acid Peeling in the Treatment of Melasma Among Egyptian Patients"],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000000065","relation":{},"ISSN":["1076-0512"],"issn-type":[{"value":"1076-0512","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}